Showing results (1-10 of 603) with videos related to
Sort By:
Pageof 61
Discovery Medicine|December 1, 2011
BRCA1 and BRCA2 mutations and breast cancerSteven A Narod, Leonardo SalmenaOncotarget|May 10, 2019
Plasma RANKL levels are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersTasnim Zaman, Ping Sun, Steven A Narod, et al.Bone Reports|September 19, 2024
Delineating the relationship between circulating osteoprotegerin and bone health in women with a pathogenic variant in BRCA1: A cross-sectional analysisAghaghia Mokhber, Elizabeth Hall, Aleksandra Uzelac, et al.Oncotarget|November 29, 2016
Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriersLovisa Odén, Mohammad Akbari, Tasnim Zaman, et al.Cancer Prevention Research (Philadelphia, Pa.)|November 4, 2015
Uninterrupted Sedentary Behavior Downregulates BRCA1 Gene ExpressionRachael Pettapiece-Phillips, Max Kotlyar, Rania Chehade, et al.Methods in Molecular Biology (Clifton, N.J.)|June 24, 2021
Pseudogenes: Four Decades of DiscoveryLeonardo SalmenaBreast Cancer Research : BCR|August 19, 2016
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specificRania Chehade, Rachael Pettapiece-Phillips, Leonardo Salmena, et al.Methods in Molecular Biology (Clifton, N.J.)|April 2, 2016
PTEN: History of a Tumor SuppressorLeonardo SalmenaMethods in Molecular Biology (Clifton, N.J.)|May 15, 2014
Pseudogene redux with new biological significanceLeonardo SalmenaThe Journal of Experimental Medicine|September 15, 2005
Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorderLeonardo Salmena, Razqallah HakemPageof 61